Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSIW) Interest & Investment Income (2022 - 2025)

TriSalus Life Sciences' Interest & Investment Income history spans 4 years, with the latest figure at $177000.0 for Q4 2025.

  • For Q4 2025, Interest & Investment Income rose 210.53% year-over-year to $177000.0; the TTM value through Dec 2025 reached $555000.0, up 37.38%, while the annual FY2025 figure was $555000.0, 37.38% up from the prior year.
  • Interest & Investment Income reached $177000.0 in Q4 2025 per TLSIW's latest filing, up from $170000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $314714.0 in Q2 2022 to a low of $35000.0 in Q1 2023.
  • Average Interest & Investment Income over 4 years is $119744.6, with a median of $101000.0 recorded in 2022.
  • Peak YoY movement for Interest & Investment Income: tumbled 88.56% in 2023, then surged 210.53% in 2025.
  • A 4-year view of Interest & Investment Income shows it stood at $105000.0 in 2022, then soared by 132.38% to $244000.0 in 2023, then crashed by 76.64% to $57000.0 in 2024, then soared by 210.53% to $177000.0 in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Interest & Investment Income are $177000.0 (Q4 2025), $170000.0 (Q3 2025), and $134000.0 (Q2 2025).